Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Renalytix plc - American Depositary Shares (NQ:RNLX)

0.2071 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Renalytix plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
Doran Brings Significant Diagnostics Sector Experience to Lead the KidneyIntelX Global Sales Effort 
From Renalytix plc
Via GlobeNewswire
Expert Ratings for Renalytix
Via Benzinga
Renalytix PLC (NASDAQ: RNLX) Near the Top of Equities by Percentage Gain on 6/30
Via Investor Brand Network
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease 
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
From Renalytix plc
Via GlobeNewswire
Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
From Renalytix plc
Via GlobeNewswire
4 Analysts Have This to Say About Renalytix
Via Benzinga
Renalytix: Q3 Earnings Insights
Via Benzinga
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
From Renalytix plc
Via GlobeNewswire
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500,... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top... 
Via Benzinga
Crude Oil Rises Over 1%; Fed's Preferred Inflation Gauge Slows In May
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500,... 
Via Benzinga
Dow Surges 200 Points; Constellation Brands Posts Upbeat Results
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 200 points on Friday. Following the market opening Friday, the Dow traded up 0.63% to 34,338.23 while the NASDAQ rose 1.05%... 
Via Benzinga
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories
New York Post 
Via Benzinga
Why Is Unicycive Therapeutics (UNCY) Down 24% Today?
Unicycive Therapeutics (UNCY) stock is falling on Friday after the medical company provided investors with an update from regulators. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Root (ROOT) Stock Down 20% Today?
Root (ROOT) stock is falling on Friday after the car insurance company's Board of Directors responded to reports of a takeover bid. 
Via InvestorPlace
Why Is Lion Group (LGHL) Stock Up 17% Today?
Lion Group (LGHL) stock is rising higher on Friday despite a lack of news from the trading platform and services company. 
Via InvestorPlace
Why Renalytix Stock Is Surging Today
Renalytix plc (NASDAQ: RNLX) shares are gaining after the FDA granted De Novo marketing authorization for its KidneyIntelX.dkd prognostic test to assess the risk of progressive kidney function decline... 
Via Benzinga
Why Is Renalytix (RNLX) Stock Up 45% Today?
Renalytix (RNLX) stock is rising higher on Friday after the medical company got marketing permission from the FDA for a kidney test. 
Via InvestorPlace
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! 
Via InvestorPlace
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For June 9, 2023
Companies Reporting Before The Bell • Yiren Digital (NYSE:YRD) is expected to report earnings for its first quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.